All In Biotech

Drug Trial Radar · NCT05096494

Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain

A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate the Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain

Last checked: Nov 20, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

76

Actual

Start

Apr 29, 2022

Primary completion

May 30, 2023

Study completion May 30, 2023

Sponsor

Lead sponsor
Scilex Pharmaceuticals, Inc.Industry
Sponsor type
Industry
Collaborators
Worldwide Clinical Trials
First posted
Oct 27, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the safety and efficacy of SP-103 in subjects with moderate to severe acute lower back pain.

Conditions

  • Moderate to Severe Acute Lower Back Pain

Interventions

  • SP-103Drug

    SP-103 topical system is worn daily for 12 hours per day for 28 days

  • PlaceboDrug

    Placebo topical system is worn daily for 12 hours per day, for 28 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Numeric Pain Rating Scale Summed Pain Intensity DifferenceTime frame: Day 1 to 7

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Research Center

    Phoenix, Arizona

  • Costal Clinical Research Specialists

    Fernandina Beach, Florida

  • Costal Clinical Research Specialists

    Jacksonville, Florida

  • Horizon Clinical Research

    Newnan, Georgia

  • Injury Care Research

    Boise, Idaho

  • Chicago Anesthesia Research Specialists

    Chicago, Illinois

  • Neuroscience Research Center

    Overland Park, Kansas

  • Neuroscience Institute, Overlook Medical Center

    Summit, New Jersey

  • Western Reserve Hospital

    Cuyahoga Falls, Ohio

  • Scilex Research Site 08

    Charleston, South Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.